{"date":"2026-08-12","count":98,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6621-2026-08-12-2225-1xzo7rd","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"22:25:48","subject":"公告本公司董事會通過115年第二季個別財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-12 22:25，「公告本公司董事會通過115年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-12-2112-q27jla","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"21:12:31","subject":"本公司董事會決議通過115年員工認股權憑證發行及認股辦法","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-12 21:12，「本公司董事會決議通過115年員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-08-12-2104-16pk5vc","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"21:04:43","subject":"公告本公司修訂「國內第一次有擔保轉換公司債發行及轉換辦法」業經金融監督管理委員會核准","clause":"第51款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-08-12 21:04，「公告本公司修訂「國內第一次有擔保轉換公司債發行及轉換辦法」業經金融監督管理委員會核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6446-2026-08-12-2043-64o7m0","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"20:43:38","subject":"媒體報導說明","clause":"第51款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-08-12 20:43，「媒體報導說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-12-2024-ozpdlc","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"20:24:43","subject":"本公司董事會決議放棄對重要子公司「鼎晉生技股份有限公司」現金增資之新股認購權利，並將此權利轉予本公司全體股東","clause":"第53款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-12 20:24，「本公司董事會決議放棄對重要子公司「鼎晉生技股份有限公司」現金增資之新股認購權利，並將此權利轉予本公司全體股東」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-12-2024-2ugmp1","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"20:24:26","subject":"公告本公司新任財務主管及公司治理主管","clause":"第8款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-12 20:24，「公告本公司新任財務主管及公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-12-2022-p3vdz5","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"20:22:05","subject":"公告本公司新任代理發言人","clause":"第8款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-12 20:22，「公告本公司新任代理發言人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-12-2021-37n2dy","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"20:21:37","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-12 20:21，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-12-1910-1artpzn","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"19:10:43","subject":"代重要子公司保盛藥業股份有限公司公告現金股利配息基準日","clause":"第14款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-12 19:10，「代重要子公司保盛藥業股份有限公司公告現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-12-1908-1qwfaew","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"19:08:44","subject":"代重要子公司保盛藥業股份有限公司公告董事會決議115年上半年盈餘分配案","clause":"第14款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-12 19:08，「代重要子公司保盛藥業股份有限公司公告董事會決議115年上半年盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-08-12-1850-134130s","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"18:50:18","subject":"代子公司普陽開發科技股份有限公司公告關係人捐贈案","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-08-12 18:50，「代子公司普陽開發科技股份有限公司公告關係人捐贈案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-08-12-1849-1ot33m2","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"18:49:47","subject":"代子公司普陽開發科技(股)公司公告評估購置廠房土地、授權動支斡旋金並進行議價相關事宜","clause":"第51款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-08-12 18:49，「代子公司普陽開發科技(股)公司公告評估購置廠房土地、授權動支斡旋金並進行議價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-08-12-1849-18gjg9w","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"18:49:14","subject":"公告本公司董事會決議註銷庫藏股暨訂定減資基準日","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-08-12 18:49，「公告本公司董事會決議註銷庫藏股暨訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-08-12-1848-160qj5l","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"18:48:41","subject":"公告本公司訂定除權息基準日及調整配息率","clause":"第14款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-08-12 18:48，「公告本公司訂定除權息基準日及調整配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-08-12-1847-173daak","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"18:47:49","subject":"公告本公司董事會通過115年度第二季合併財務報表","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-08-12 18:47，「公告本公司董事會通過115年度第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-08-12-1837-9btgih","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"18:37:21","subject":"公告本公司董事會決議通過115年度第一次員工認股權憑證發行及認股辦法","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-08-12 18:37，「公告本公司董事會決議通過115年度第一次員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-08-12-1832-1kd7c9e","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"18:32:27","subject":"公告本公司設置資安主管","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-08-12 18:32，「公告本公司設置資安主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-08-12-1831-c2trgg","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"18:31:51","subject":"公告本公司公司治理主管任命案","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-08-12 18:31，「公告本公司公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-08-12-1830-37n2dy","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"18:30:42","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-08-12 18:30，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-08-12-1811-1v332z0","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"18:11:07","subject":"公告本公司115年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-08-12 18:11，「公告本公司115年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-08-12-1809-1t6ta18","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"18:09:35","subject":"公告本公司董事會通過115年第2季合併財務報告XXXXXXXXXXXXXXXXXXXXXXXXXXXXXX","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-08-12 18:09，「公告本公司董事會通過115年第2季合併財務報告XXXXXXXXXXXXXXXXXXXXXXXXXXXXXX」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-08-12-1806-1oriwsg","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"18:06:44","subject":"公告本公司董事會通過115年度第2季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-08-12 18:06，「公告本公司董事會通過115年度第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-08-12-1757-1g4rk7b","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:57:15","subject":"公告本公司董事會通過115年第二季財務報表","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-08-12 17:57，「公告本公司董事會通過115年第二季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-08-12-1748-17qvvm5","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:48:44","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-08-12 17:48，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-08-12-1729-1vj8eem","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:29:46","subject":"本公司獨立董事對董事會議決事項表示反對意見","clause":"第44款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-08-12 17:29，「本公司獨立董事對董事會議決事項表示反對意見」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-08-12-1729-v9rlyt","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:29:15","subject":"公告本公司董事會委任第六屆薪酬委員會成員","clause":"第6款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-08-12 17:29，「公告本公司董事會委任第六屆薪酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-08-12-1728-1o5sa57","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:28:37","subject":"公告本公司董事會決議辦理註銷限制員工權利新股股份，訂定減資基準日案","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-08-12 17:28，「公告本公司董事會決議辦理註銷限制員工權利新股股份，訂定減資基準日案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-08-12-1727-16q9e0t","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:27:59","subject":"公告本公司董事會通過115年度第二季合併財報","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-08-12 17:27，「公告本公司董事會通過115年度第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-08-12-1727-cbf1o5","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:27:36","subject":"本公司受邀參加花旗環球證券之2026Q2線上法說會議","clause":"第12款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-08-12 17:27，「本公司受邀參加花旗環球證券之2026Q2線上法說會議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-12-1727-1oixrch","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:27:02","subject":"公告本公司發言人異動事宜","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-12 17:27，「公告本公司發言人異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-08-12-1725-isqttc","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:25:12","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-08-12 17:25，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-08-12-1724-7n8ndi","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:24:40","subject":"代子公司啟安國際生醫投資股份有限公司公告簡易合併債權人通知","clause":"第44款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-08-12 17:24，「代子公司啟安國際生醫投資股份有限公司公告簡易合併債權人通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-12-1724-gey8f1","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:24:36","subject":"公告本公司總經理異動事宜","clause":"第6款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-12 17:24，「公告本公司總經理異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-12-1723-19b1djy","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:23:34","subject":"公告本公司配合會計師事務所內部輪調變更會計師","clause":"第7款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-12 17:23，「公告本公司配合會計師事務所內部輪調變更會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-12-1722-9769qc","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:22:23","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-12 17:22，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-08-12-1722-17qvvm5","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:22:15","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-08-12 17:22，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-08-12-1721-ii13w5","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:21:35","subject":"公告本公司董事會決議通過114年度第一次發行之員工認股權憑證部分獲配人員放棄認股權利","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-08-12 17:21，「公告本公司董事會決議通過114年度第一次發行之員工認股權憑證部分獲配人員放棄認股權利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-08-12-1711-ctseho","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:11:41","subject":"(更正)本公司115年度第二季財務報告經董事會決議通過","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-08-12 17:11，「(更正)本公司115年度第二季財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-08-12-1711-37n2dy","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:11:25","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-08-12 17:11，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-08-12-1708-1e1q4kh","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:08:43","subject":"公告本公司董事會通過115年度第二季財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-08-12 17:08，「公告本公司董事會通過115年度第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-08-12-1705-1uoak12","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"17:05:19","subject":"公告本公司115年第2季合併財務報告經簽證會計師出具保留結論之核閱報告","clause":"第24款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-08-12 17:05，「公告本公司115年第2季合併財務報告經簽證會計師出具保留結論之核閱報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-08-12-1700-q28ibs","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"17:00:23","subject":"公告本公司115年度第二季財務報告董事會預計召開日期為115年8月20日","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-08-12 17:00，「公告本公司115年度第二季財務報告董事會預計召開日期為115年8月20日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-08-12-1654-1n3tsvw","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:54:25","subject":"本公司115年度第二季財務報告經董事會決議通過","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-08-12 16:54，「本公司115年度第二季財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-08-12-1648-yniuci","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"16:48:02","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-08-12 16:48，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-08-12-1648-17qvvm5","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:48:01","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-08-12 16:48，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-08-12-1645-1yhm3s8","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"16:45:24","subject":"公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第二款及第四款之公告標準","clause":"第22款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-08-12 16:45，「公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第二款及第四款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-08-12-1644-6zb90s","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"16:44:41","subject":"公告本公司董事會通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-08-12 16:44，「公告本公司董事會通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-08-12-1640-1mfntc2","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"16:40:48","subject":"本公司民國115年第二季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-08-12 16:40，「本公司民國115年第二季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-08-12-1640-cypi6g","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"16:40:39","subject":"本公司董事會決議辦理註銷庫藏股並訂定減資基準日","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-08-12 16:40，「本公司董事會決議辦理註銷庫藏股並訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-08-12-1640-37n2dy","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"16:40:30","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-08-12 16:40，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-08-12-1640-tjxx6d","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"16:40:27","subject":"本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-08-12 16:40，「本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-08-12-1639-ozm3og","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:39:09","subject":"代子公司啟安國際生醫投資股份有限公司公告簡易合併案","clause":"第9款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-08-12 16:39，「代子公司啟安國際生醫投資股份有限公司公告簡易合併案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-08-12-1638-qgli5","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:38:06","subject":"公告本公司董事會通過115年第二季財務報告。","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-08-12 16:38，「公告本公司董事會通過115年第二季財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-08-12-1632-c6ibsk","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:32:56","subject":"公告本公司董事會通過設置永續長","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-08-12 16:32，「公告本公司董事會通過設置永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-08-12-1631-37n2dy","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:31:55","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-08-12 16:31，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-08-12-1625-oihymi","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"16:25:28","subject":"本公司受邀參加櫃買中心舉辦之「櫃買市場業績發表會」","clause":"第12款","fact_date":"2026-08-17","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-08-12 16:25，「本公司受邀參加櫃買中心舉辦之「櫃買市場業績發表會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-08-12-1625-12nvdnc","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:25:14","subject":"公告本公司董事會通過董事長兼任總經理","clause":"第6款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-08-12 16:25，「公告本公司董事會通過董事長兼任總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3184-2026-08-12-1620-2zhtam","company_id":"3184","company":"微邦","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:20:30","subject":"更正本公司115年第2季iXBRL公告資訊","clause":"第44款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：微邦（3184），2026-08-12 16:20，「更正本公司115年第2季iXBRL公告資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-08-12-1618-ghdsnc","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:18:20","subject":"公告本公司董事會通過研發主管任命案","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-08-12 16:18，「公告本公司董事會通過研發主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-08-12-1615-5rax5d","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:15:58","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-08-12 16:15，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-08-12-1615-drgvb6","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:15:14","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-08-12 16:15，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-08-12-1613-1h148f4","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:13:15","subject":"本公司董事會通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-08-12 16:13，「本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-08-12-1612-i7t6nw","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:12:29","subject":"公告本公司董事會通過115年上半年度財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-08-12 16:12，「公告本公司董事會通過115年上半年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-08-12-1601-l7qirp","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:01:17","subject":"公告本公司會計主管異動","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-08-12 16:01，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-08-12-1600-1ur6s63","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"16:00:56","subject":"公告本公司財務長異動","clause":"第11款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-08-12 16:00，「公告本公司財務長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-08-12-1559-11wjw0o","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"15:59:48","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-08-12 15:59，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-08-12-1559-1xeokz6","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"15:59:25","subject":"公告本公司董事會通過115年第2季合併財務報表","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-08-12 15:59，「公告本公司董事會通過115年第2季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-08-12-1559-gi3647","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:59:18","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第41款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-08-12 15:59，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-08-12-1558-2sx0rb","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:58:22","subject":"本公司董事會通過115年第二季合併財報","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-08-12 15:58，「本公司董事會通過115年第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-08-12-1557-s3fqjw","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:57:24","subject":"公告本公司董事會決議通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-08-12 15:57，「公告本公司董事會決議通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-08-12-1557-1qbs1ch","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"15:57:08","subject":"公告本公司董事長訂定民國115年第2季盈餘之除息基準日","clause":"第14款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-08-12 15:57，「公告本公司董事長訂定民國115年第2季盈餘之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-08-12-1554-qbpkpx","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:54:39","subject":"代重要子公司居禮股份有限公司公告董事會決議發行員工認股權憑證","clause":"第9款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-08-12 15:54，「代重要子公司居禮股份有限公司公告董事會決議發行員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-08-12-1552-lqhkh","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:52:36","subject":"公告本公司協理晉升案","clause":"第8款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-08-12 15:52，「公告本公司協理晉升案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-08-12-1552-1we3v5x","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:52:11","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告","clause":"第23款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-08-12 15:52，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-08-12-1552-isqttc","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:52:09","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-08-12 15:52，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-08-12-1551-y4yoeo","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:51:48","subject":"本公司董事會決議分派115年第二季盈餘","clause":"第14款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-08-12 15:51，「本公司董事會決議分派115年第二季盈餘」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-08-12-1551-37n2dy","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:51:10","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-08-12 15:51，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-08-12-1549-61p8d8","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:49:18","subject":"本公司依公開發行公司資金貸與背書保證處理準則第二十二條第一項第三款之規定辦理公告","clause":"第20款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-08-12 15:49，「本公司依公開發行公司資金貸與背書保證處理準則第二十二條第一項第三款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-08-12-1538-17d3h5v","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"15:38:01","subject":"公告本公司現金增資股款催繳公告","clause":"第53款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-08-12 15:38，「公告本公司現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-08-12-1533-5rax5d","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:33:39","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-08-12 15:33，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-08-12-1533-1ctb9ez","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:33:03","subject":"公告本公司提報董事會115年度第二季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-08-12 15:33，「公告本公司提報董事會115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-08-12-1530-pcpix1","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"15:30:39","subject":"公告本公司董事會提報民國115年第二季合併財務報表","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-08-12 15:30，「公告本公司董事會提報民國115年第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-08-12-1526-81os3q","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:26:09","subject":"公告本公司董事會決議通過115年度第二季合併財務報表","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-08-12 15:26，「公告本公司董事會決議通過115年度第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-08-12-1523-1eaiuug","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:23:40","subject":"公告本公司董事會決議委任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-08-12 15:23，「公告本公司董事會決議委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-08-12-1523-1j7xe","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:23:07","subject":"公告115年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-08-12 15:23，「公告115年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-08-12-1520-1avz4pv","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:20:57","subject":"公告本公司董事會通過解除經理人之競業禁止","clause":"第22款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-08-12 15:20，「公告本公司董事會通過解除經理人之競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-08-12-1516-sn763a","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"15:16:58","subject":"公告本公司董事會決議通過115年第2季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-08-12 15:16，「公告本公司董事會決議通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-08-12-1505-4mdqob","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:05:02","subject":"代重要子公司台灣泰福生技股份有限公司公告財會主管暨主辦會計異動","clause":"第8款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-08-12 15:05，「代重要子公司台灣泰福生技股份有限公司公告財會主管暨主辦會計異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-08-12-1504-9yg3n7","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:04:29","subject":"公告本公司財務長、代理發言人及內部稽核主管異動","clause":"第8款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-08-12 15:04，「公告本公司財務長、代理發言人及內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-08-12-1503-37n2dy","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"15:03:47","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-08-12 15:03，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-08-12-1449-fjxfcq","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"14:49:29","subject":"公告本公司薪資報酬委員會異動","clause":"第6款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-08-12 14:49，「公告本公司薪資報酬委員會異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-08-12-1415-37n2dy","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"14:15:15","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-08-12 14:15，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-08-12-1411-1ms5deh","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"14:11:08","subject":"本公司受邀參加櫃買中心舉辦之櫃買市場業績發表會","clause":"第12款","fact_date":"2026-08-17","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-08-12 14:11，「本公司受邀參加櫃買中心舉辦之櫃買市場業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-08-12-1410-yniuci","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-08-12","time":"14:10:55","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-08-12 14:10，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-08-12-1350-1kdb6sh","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"13:50:46","subject":"公告本公司第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-08-12 13:50，「公告本公司第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-08-12-1349-eap7d9","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"13:49:24","subject":"公告本公司115年第二季合併財務報告提報董事會","clause":"第31款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-08-12 13:49，「公告本公司115年第二季合併財務報告提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-08-12-1152-10jca0t","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-08-12","time":"11:52:43","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-08-12 11:52，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-12-0405-yo3adc","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-12","time":"04:05:52","subject":"代重要子公司Belite Bio, Inc公告LBS-008用於治療斯特格病變之新藥查驗登記申請(NDA)獲美國食品藥物管理局(FDA)受理並授予優先審查資格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-12 04:05，「代重要子公司Belite Bio, Inc公告LBS-008用於治療斯特格病變之新藥查驗登記申請(NDA)獲美國食品藥物」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}